A division of ADPEN Laboratories, Inc. located in Florida, with over 30 years providing analytical services to the pharmaceutical industry has expanded its operations from a Contract Research Organization (CRO) to also a Contract Manufacturing Organization.
Formulation development for new chemical (NCE) and new biological (NBE) entities and generic OTC and Rx. Optimization of existing formulations
Process development for specific dosage forms
Improving delivery of existing dosage forms
Developing controlled release, sustained release, and complex formulations
Dedicated suites for the handling of DEA Scheduled Compounds
Support of clinical-niche
ADPEN offers a broad range of analytical services, stability, microbiological, physical, biochemical and chemical, improcess and batch release testing. Development, validation and transfer of methods.
We are open to opportunities for partnerships that will help advance our pipeline and achieve our mission to develop and commercialize generic Rx and Novel drugs by translating innovative science into generic and new medicines that improve patients’ lives.
If you would like to find out more, please email us at: firstname.lastname@example.org